ValuEngine Downgrades LHC Group (LHCG) to Hold

LHC Group (NASDAQ:LHCG) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

LHCG has been the topic of several other research reports. SunTrust Banks restated a “buy” rating and set a $75.00 price objective on shares of LHC Group in a report on Friday, November 3rd. Royal Bank Of Canada boosted their price objective on LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Zacks Investment Research downgraded LHC Group from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Oppenheimer upped their target price on LHC Group from $68.00 to $80.00 and gave the company an “outperform” rating in a report on Tuesday, November 7th. Finally, Bank of America initiated coverage on LHC Group in a report on Monday, August 21st. They issued a “buy” rating and a $76.00 target price on the stock. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $77.10.

Shares of LHC Group (NASDAQ LHCG) opened at $65.43 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market capitalization of $1,195.99, a PE ratio of 28.08, a price-to-earnings-growth ratio of 1.94 and a beta of 0.69. LHC Group has a twelve month low of $41.66 and a twelve month high of $76.14.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.04. The firm had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The business’s revenue for the quarter was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.54 EPS. equities analysts expect that LHC Group will post 2.4 earnings per share for the current year.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the transaction, the chief operating officer now owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Federated Investors Inc. PA grew its stake in shares of LHC Group by 4.2% in the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after buying an additional 66 shares in the last quarter. Acrospire Investment Management LLC grew its stake in shares of LHC Group by 30.8% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after buying an additional 400 shares in the last quarter. Cubist Systematic Strategies LLC grew its stake in shares of LHC Group by 758.0% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after buying an additional 1,516 shares in the last quarter. First Mercantile Trust Co. bought a new stake in shares of LHC Group in the 2nd quarter valued at approximately $147,000. Finally, SG Americas Securities LLC bought a new stake in shares of LHC Group in the 3rd quarter valued at approximately $163,000. 85.25% of the stock is owned by institutional investors and hedge funds.

WARNING: This article was first posted by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/12/03/valuengine-downgrades-lhc-group-lhcg-to-hold.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply